TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer

Clinical trial NCT00052065 · COMPLETED

Trial details

NCT number: NCT00052065
Sponsor: Telik
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms

Start date: 2003-02-01
Primary completion: 2006-03-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.